Reuters - Novartis AG’s cancer drug Glivec failed
to meet its main target in a late-stage study of patients with
chronic myeloid leukemia (CML), the Swiss drugmaker said on
Friday.
Independent honest reviews of most effective natural herbal supplements
Reuters - Novartis AG’s cancer drug Glivec failed
to meet its main target in a late-stage study of patients with
chronic myeloid leukemia (CML), the Swiss drugmaker said on
Friday.
The URI to TrackBack this entry is: http://herbal-review.com/2008/06/13/novartis-says-glivec-misses-main-goal-in-study-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|glivec |Results by Google for Nubiles Girls
23 queries. 4.909 seconds